Cargando…

Careful Breakthrough Cancer Pain Treatment through Rapid-Onset Transmucosal Fentanyl Improves the Quality of Life in Cancer Patients: Results from the BEST Multicenter Study

Objectives: To explore the effect of breakthrough cancer pain (BTcP) treatment on quality of sleep and other aspects of the health-related quality of life (HRQoL) in patients with cancer pain. Methods: In an observational, multicenter, cohort study, cancer patients from palliative care units, oncolo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cuomo, Arturo, Cascella, Marco, Forte, Cira Antonietta, Bimonte, Sabrina, Esposito, Gennaro, De Santis, Stefano, Cavanna, Luigi, Fusco, Flavio, Dauri, Mario, Natoli, Silvia, Maltoni, Marco, Morabito, Alessandro, Mediati, Rocco Domenico, Lorusso, Vito, Barni, Sandro, Porzio, Giampiero, Mercadante, Sebastiano, Crispo, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230287/ https://www.ncbi.nlm.nih.gov/pubmed/32252426 http://dx.doi.org/10.3390/jcm9041003

Ejemplares similares

Multidimensional Statistical Technique for Interpreting the Spontaneous Breakthrough Cancer Pain Phenomenon. A Secondary Analysis from the IOPS-MS Study
por: Cascella, Marco, et al.
Publicado: (2021)

Transmucosal fentanyl vs intravenous morphine in doses proportional to basal opioid regimen for episodic-breakthrough pain
por: Mercadante, S, et al.
Publicado: (2007)

Fentanyl transmucosal tablets: current status in the management of cancer-related breakthrough pain
por: Prommer, Eric, et al.
Publicado: (2012)

Multimodal approaches and tailored therapies for pain management: the trolley analgesic model
por: Cuomo, Arturo, et al.
Publicado: (2019)

The Role of Anti-Nerve Growth Factor Monoclonal Antibodies in the Control of Chronic Cancer and Non-Cancer Pain
por: Bimonte, Sabrina, et al.
Publicado: (2021)

An Overview on the Potential Roles of EGCG in the Treatment of COVID-19 Infection
por: Bimonte, Sabrina, et al.
Publicado: (2021)

A new transmucosal drug delivery system for patients with breakthrough cancer pain: the fentanyl effervescent buccal tablet
por: Freye, Enno
Publicado: (2008)

A Longitudinal Study of Breakthrough Cancer Pain: An Extension of IOPS-MS Study
por: Mercadante, Sebastiano, et al.
Publicado: (2021)

Advantages and issues of concern regarding approaches to peripheral nerve block for total hip arthroplasty
por: Crisci, Marco, et al.
Publicado: (2021)

Safety and Efficacy of Oral Transmucosal Fentanyl Citrate Compared to Morphine Sulphate Immediate Release Tablet in Management of Breakthrough Cancer Pain
por: Bhatnagar, Sushma, et al.
Publicado: (2014)

Association of a Risk Evaluation and Mitigation Strategy Program With Transmucosal Fentanyl Prescribing
por: Fleischman, William, et al.
Publicado: (2019)

COVID-Pain: Acute and Late-Onset Painful Clinical Manifestations in COVID-19 – Molecular Mechanisms and Research Perspectives
por: Cascella, Marco, et al.
Publicado: (2021)

Oral transmucosal fentanyl citrate in cancer pain management: a practical application of nanotechnology
por: Mystakidou, Kyriaki, et al.
Publicado: (2007)

Efficacy of Oral Transmucosal Fentanyl Citrate for Premedication in Patients for Surgery under General Anesthesia
por: Singh, Raj Bahadur, et al.
Publicado: (2017)

Oral transmucosal fentanyl citrate analgesia in prehospital trauma care: an observational cohort study
por: Pietsch, Urs, et al.
Publicado: (2023)

Multiple effectiveness aspects of tapentadol for moderate–severe cancer-pain treatment: an observational prospective study
por: Cascella, M, et al.
Publicado: (2018)

The effects of naloxone on human breast cancer progression: in vitro and in vivo studies on MDA.MB231 cells
por: Bimonte, Sabrina, et al.
Publicado: (2018)

Strategies to evaluate outcomes in long-COVID-19 and post-COVID survivors
por: Crispo, Anna, et al.
Publicado: (2021)

Development of Federally Mandated Risk Evaluation and Mitigation Strategies (REMS) for Transmucosal Immediate-Release Fentanyl Products
por: Pergolizzi, Joseph V, et al.
Publicado: (2013)

Toward more focused multimodal and multidisciplinary approaches for pain management in Parkinson’s disease
por: Cuomo, Arturo, et al.
Publicado: (2019)

Rapid and Impressive Response to a Combined Treatment with Single-Dose Tocilizumab and NIV in a Patient with COVID-19 Pneumonia/ARDS
por: Cascella, Marco, et al.
Publicado: (2020)

Breakthrough Cancer Pain: Preliminary Data of The Italian Oncologic Pain Multisetting Multicentric Survey (IOPS-MS)
por: Mercadante, Sebastiano, et al.
Publicado: (2016)

Could the perioperative use of opioids influence cancer outcomes after surgery? A scoping review protocol
por: Cascella, Marco, et al.
Publicado: (2022)

Factors Influencing the Clinical Presentation of Breakthrough Pain in Cancer Patients
por: Mercadante, Sebastiano, et al.
Publicado: (2018)

Current shreds of evidence on the anticancer role of EGCG in triple negative breast cancer: an update of the current state of knowledge
por: Bimonte, Sabrina, et al.
Publicado: (2020)

Fentanyl Sublingual Spray for Breakthrough Pain in Cancer Patients
por: Zeppetella, Giovambattista
Publicado: (2013)

Silica Nanoparticles in Transmucosal Drug Delivery
por: M. Ways, Twana Mohammed, et al.
Publicado: (2020)

The roles of epigallocatechin-3-gallate in the treatment of neuropathic pain: an update on preclinical in vivo studies and future perspectives
por: Bimonte, Sabrina, et al.
Publicado: (2017)

The efficacy of Epigallocatechin-3-gallate (green tea) in the treatment of Alzheimer’s disease: an overview of pre-clinical studies and translational perspectives in clinical practice
por: Cascella, Marco, et al.
Publicado: (2017)

An open-label clinical trial of oral transmucosal haloperidol and oral transmucosal olanzapine in the treatment of terminal delirium at home
por: Lyu, Xiao-Juan, et al.
Publicado: (2022)

Feasibility of a transmucosal sublingual fentanyl tablet as a procedural pain treatment in colonoscopy patients: a prospective placebo-controlled randomized study
por: Fihlman, Mari, et al.
Publicado: (2020)

Pharmacokinetic Characterisation and Comparison of Bioavailability of Intranasal Fentanyl, Transmucosal, and Intravenous Administration through a Three-Way Crossover Study in 24 Healthy Volunteers
por: Nardi-Hiebl, S., et al.
Publicado: (2021)

Role of intranasal fentanyl in breakthrough pain management in cancer patients
por: Leppert, Wojciech
Publicado: (2010)

Single-dose fentanyl sublingual spray for breakthrough cancer pain
por: Taylor, Donald R
Publicado: (2013)

The Prevalence and Characteristics of Breakthrough Cancer Pain in Patients Receiving Low Doses of Opioids for Background Pain
por: Mercadante, Sebastiano, et al.
Publicado: (2021)

Transmucosal Absorption Enhancers in the Drug Delivery Field
por: Maher, Sam, et al.
Publicado: (2019)

The Potential of Films as Transmucosal Drug Delivery Systems
por: de Carvalho, Ana Clara Wada, et al.
Publicado: (2023)

The role of general anesthetics and the mechanisms of hippocampal and extra-hippocampal dysfunctions in the genesis of postoperative cognitive dysfunction
por: Cascella, Marco, et al.
Publicado: (2017)

The Potential Roles of Epigallocatechin-3-Gallate in the Treatment of Ovarian Cancer: Current State of Knowledge
por: Bimonte, Sabrina, et al.
Publicado: (2020)

Intranasal Fentanyl for Intervention-Associated Breakthrough Pain After Cardiac Surgery
por: Valtola, Antti, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_glitf7bm1d4al357f4ilvvrqku